Full-Time

Case Management QA Vendor Sr Associate

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior

Hyderabad, Telangana, India

Category
QA & Testing
Quality Assurance
Required Skills
Data Analysis
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Amgen referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Master’s degree and 3 years of directly related experience (OR)
  • Bachelor’s degree and 5 years of directly related experience (OR)
  • Associate’s degree and 10 years of directly related experience (OR)
  • High school diploma / GED and 12 years of directly related experience (AND)
  • Previous experience directly managing teams, projects, programs or directing the allocation of resources
Responsibilities
  • Support interactions with business partners (license partners) and vendors for all case intake and processing activities.
  • Vendor oversight of all case intake and processing activities and case quality including analysis and reporting of trends in quality measures.
  • Ensure vendor compliance with approved processes and training requirements.
  • Submission of all individual case safety reports to FDA/EMA, business partners (license partners), and vendors.
  • Act as US/EU local safety office and FDA/EMA point of contact for safety reporting.
  • Provide audit & external inspection support.
  • Assist in assuring quality of Individual Case Safety Report (ICSR) processing globally for clinical trial and post-market cases processed by vendors.
  • Ensure Vendors deliver high quality cases through metric management meet all worldwide regulatory authority requirements.
  • Provide vendors with resources and training to perform their role.
  • Analysis and communication of case Quality Control results.
  • Responsible for escalation of case related issues from vendor(s).
  • Providing audit/inspection support for case management related activities, including liaising with vendors to provide support as applicable.
  • Undertaking activities delegated by the Qualified Person for Pharmacovigilance (QPPV) as detailed in the PV System Master File and maintain a state of inspection readiness.
  • May assist with Periodic Aggregate Safety Reports (PASR) processes and associated metrics throughout the product lifecycle as applicable.
  • Other duties related to the position as necessary as defined in Standard Operating Procedures or as requested by their supervisor.
  • Work within the Quality Management System framework including all applicable training and controlled documentation governing Pharmacovigilance processes.
  • Ensure vendor case processing timelines for AE intake, triage and submission are met.
  • Perform retrospective quality assurance of vendor processed cases.
  • Day-to-day vendor management issues.
  • Interact with other local safety offices as applicable.
  • Support on-boarding and off-boarding of vendor staff.
  • Attend management meetings with vendors.
  • Support analysis of QC trends.
  • Support generating, communicating, and archiving of reports of QC findings.
  • Support audits of CAPAs and other actions/recommendations for ICSR quality related measures.
  • Perform case review as required.
  • Generate and distribute performance metrics (retro QA / Case correction).
  • Support analysis of QC trends including actions/recommendations.
Desired Qualifications
  • Understanding of global regulatory requirements for pharmacovigilance
  • Proficiency in safety case processing
  • Expertise in all aspects of case intake and processing in multiple global safety databases
  • Experience in supporting inspections or internal audits
  • Communication skills and attention to detail
  • Microsoft Suite: Word, Excel, PowerPoint, Project, Outlook

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.